Immunity Group Australia specializes in translational research and development of food allergy diagnostic methods, utilizing the basophil activation test to accurately identify food adverse reactions. The company addresses the need for effective diagnostics and treatment options for individuals suffering from food allergies and related immune disorders.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with food allergies often face challenges in accurately identifying the specific allergens causing adverse reactions, leading to difficulties in managing their condition and potential health risks. Current diagnostic methods may lack the precision needed for effective treatment and prevention strategies.
Solution
Immunity Group Australia specializes in translational research and development of advanced food allergy diagnostic methods, focusing on improving the accuracy and reliability of identifying food adverse reactions. The company utilizes the basophil activation test (BAT), a state-of-the-art diagnostic tool, to provide precise insights into an individual's allergic responses. By employing cutting-edge technology and testing methodologies, Immunity Group Australia aims to enhance the management of food allergies and related immune disorders, offering resources and education to empower individuals in leading healthier lives. The company also collaborates on projects related to gut health research and immunity enhancement, striving to advance the understanding and treatment of immune-related conditions.
Target Audience
The primary target audience includes individuals suffering from food allergies and related immune disorders, as well as healthcare professionals seeking advanced diagnostic tools and treatment options.
Features
- Development of novel applications for the basophil activation test (BAT) for accurate food allergy diagnostics.
- Focus on translational research to bridge the gap between laboratory findings and clinical applications.
- Collaborative projects across the Indo-Pacific region to advance biotechnology and life sciences in immunology and microbiome research.
- Educational resources and courses designed to empower individuals with knowledge about food adverse reactions, microbiome health, and immunology.
- Development of the Microbiome Diversification Protocol with Allergen (MDPA) for oral immunotherapy.